SUBMITTED BYRUPALI

HIMANSHI
GHOUSIA
PRATEEK

MERGER OF

GSK is a British multinational pharmaceutical, biologics, vaccines and consumer

healthcare company.
GLOBAL HEADQUATERS-UK at GSK House in Brentford, a suburb of west
London, and its US headquarters are in The Navy Yard, Philadelphia and Research
Triangle Park, North Carolina.
OFFICES- over 115 countries
ESTABLISHMENT-2000 (by the merger of Glaxo Wellcome and SmithKline Beecham)
MARKET CAPITALISATION- 79 billion, (as on 2 may 2014)
CEO- Andrew Witty since May 2008.
EMPLOYEES- over 99,000 people, 12,500 of whom work in research and development.
CONTROVERSIES-In July 2012 GSK pleaded guilty to criminal charges and agreed to
a pay $3 billion to settle the criminal charges as well as civil qui tam lawsSuit.

PRODUCTS- drugs and vaccines for major disease areas such as asthma, cancer,
infections, diabetes, digestive and mental health conditions, the biggest selling of
which were Advair, Avodart , Flovent , Augmentina, Lovaza, and Lamictal in
2013. Its drugs and vaccines earned 21.3 billion in 2013.
Top-selling products include its asthma/COPD therapeutics Advair, Ventolin, and
Flovent.
Its consumer healthcare division, which earned 5.2 billion in 2013, sells oral healthcare,
and nutritional products, drinks and over-the-counter medicines,
including Sensodyne, Boost and Horlicks.
The company's over-the-counter health-care products include Abreva to treat cold
sores; Aquafresh, Maclean's and Sensodyne toothpastes; Night Nurse, a cold remedy;
Breathe Right nasal strips. It also sells several drinks, including Horlicks, a malted
milk drink and Boost, a chocolate-flavoured drink.].

GLAXO WELLCOME

Burroughs Wellcome & Company was founded in 1880 in London by the

American pharmacists Henry Wellcome and Silas Burroughs.[11]The Wellcome
Tropical Research Laboratories opened in 1902.[12]

Glaxo was founded in Bunnythorpe, New Zealand, in 1904. It was originally a

baby food manufacturer, processing milk into a baby food of the same name.
The product was sold under the slogan "Glaxo builds bonny babies" from 1908.
Still visible on the main street of Bunnythorpe is a dairy factory (factory for
drying and processing cows' milk into powder) with the original Glaxo logo
clearly visible; it is now a car repair shop.[11]

Glaxo became Glaxo Laboratories and opened new units in London in 1935.
Glaxo Laboratories bought two companies, Joseph Nathan and Allen &
Hanburys in 1947 and 1958 respectively. After the company bought Meyer
Laboratories in 1978, it started to play an important role in the US market. In
1983 the American arm, Glaxo Inc., moved to Research Triangle Park (US
headquarters/research) and Zebulon (US manufacturing) in North Carolina.

In March 1995 Glaxo and Burroughs Wellcome Co. merged to form Glaxo
Wellcome.[11][13][14] In that year Glaxo restructured is R&D operation, cutting
about 10,000 jobs worldwide, closing its research and development facility in
Beckenham, Kent, which was formerly Wellcome's principal research and
development facility in the United Kingdom, and opening a Medicines Research
Centre at Stevenage in England[15][16][17] Also in that year, Glaxo Wellcome
acquired the California-based Affymax, a leader in the field ofcombinatorial
chemistry.[18] Valtrex (valaciclovir) was launched as an anti-herpes successor to
Zovirax (acyclovir).

The research center of GlaxoSmithKline in the business cluster of ParisSaclay, France.

In 1999 Glaxo Wellcome was the world's third-largest pharmaceutical company

by revenues (behind Novartis and Merck), with a global market share of around
4 per cent.[19] Glaxo Wellcome's products included Imigran (for the treatment of
migraine), salbutamol (Ventolin) (for the treatment of asthma), Zovirax (for the
treatment of coldsores), and Retrovir and Epivir (for the treatment of
AIDS).[20] As of 2000, seven of Glaxo Wellcome's products were among the
world's top 50 best-selling pharmaceutical products[20] and was the world's
largest maker of drugs for the treatment of asthma and HIV/AIDS.[21] It
employed around 59,000 people worldwide, of whom around 13,400 were based
in the United Kingdom.[20] Glaxo Wellcome had 76 operating companies.[20] It
had 50 manufacturing facilities worldwide.[20] In the United Kingdom, the
company had research and development facilities at Ware and Stevenage,
Hertfordshire; Dartford and Beckenham, Kent; and Greenford in London.[20] It
had manufacturing plants in the UK at Ulverston in Cumbria, Barnard Castle in
County Durham, Speke on Merseyside and Montrose in north-east
Scotland.[20] Outside of the UK, Glaxo Wellcome had research and development
centres in North Carolina, United States and Japan, and production facilities in
the United States, Europe and Far East.[20]

Glaxo Wellcome and SmithKline Beecham announced their intention to merge

on 17 January 2000. The merger was completed in December that year, forming
GlaxoSmithKline (GSK).[22][23]

SMITH KLINE BEECHAM

In 1843 Thomas Beecham launched his Beecham's Pills laxative in England giving
birth to the Beecham Group.[11] Beecham opened its first factory in St
Helens, Lancashire, England, for rapid production of medicines in 1859. The
original factory was closed in 1994 and passed to the local college for redevelopment. By the 1960s Beecham was extensively involved in
pharmaceuticals.
In 1830 John K. Smith opened its first pharmacy in Philadelphia. In 1865 Mahlon
Kline joined the business, which 10 years later became Smith, Kline & Co. In 1891
it merged with French, Richard and Company. It changed its name to Smith
Kline & French Laboratories in 1929 as it focused more on research. Years later
Smith Kline & French Laboratories opened a new laboratory in Philadelphia; it
then bought Norden Laboratories, a business doing research into animal health.
Smith Kline & French Laboratories bought Recherche et Industrie
Thrapeutiques (Belgium) in 1963 to focus on vaccines. The company started to
expand globally, buying seven laboratories in Canada and the US in 1969. In 1982
it bought Allergan, a manufacturer of eye and skincare products. The company
merged with Beckman Inc. later that year and changed its name to SmithKline
Beckman.[11]
In 1988 SmithKline Beckman bought its biggest competitor, International
Clinical Laboratories, and in 1989 merged with Beecham to form SmithKline
Beecham plc. The headquarters of the company was moved to England. To
expand research and development in the US, SmithKline Beecham bought a new
research center in 1995. Another new research centre at New Frontiers Science
Park in Harlow, England, was opened in 1997.[11]
Glaxo Wellcome and SmithKline Beecham announced their intention to merge
on 17 January 2000. The merger was completed in December that year, forming
GlaxoSmit

ACQUISITION OF